Brief Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 28, 2012; 18(8): 840-846
Published online Feb 28, 2012. doi: 10.3748/wjg.v18.i8.840
Table 1 The clinical data of 134 pancreatic ductal adenocarcinoma patients
ItemsCategoryn (%)
Age (yr) ≤ 6063 (47.0)
> 6071 (53.0)
GenderMale92 (68.7)
Female42 (31.3)
Location of tumorHead97 (72.4)
Body/tail37 (27.6)
Size of tumor (cm)1 ≤ 2.017 (13.2)
> 2.0112 (86.8)
Histological gradeG13 (2.2)
G2116 (86.6)
G315 (11.2)
Perineural invasionAbsent25 (18.7)
Present109 (81.3)
pT1T110 (7.6)
T243 (32.8)
T346 (35.1)
T432 (24.4)
pN1Absent84 (65.1)
Present45 (34.9)
pTNM1I32 (24.8)
II30 (23.3)
III33 (25.6)
IV34 (26.4)
Table 2 Correlation of fibroblast activation protein expression with clinicopathological features of pancreatic ductal adenocarcinoma patients n (%)
ItemsCategorynFAP negativeFAP positiveP value
Age (yr) ≤ 606319 (30.2)44 (69.8)0.000
> 607113 (18.3)58 (81.7)
GenderMale9222 (23.9)70 (76.1)0.990
Female4210 (23.8)32 (76.2)
Location of tumorHead9727 (27.8)70 (72.2)0.082
Body/tail375 (13.5)32 (86.5)
Size of tumor (cm)1 ≤ 2.01710 (58.8)7 (41.2)0.000
> 2.011221 (18.8)91 (81.2)
Histological gradeG131 (33.3)2 (66.7)0.889
G211627 (23.3)89 (76.7)
G3154 (26.7)11 (73.3)
Fibrotic focusAbsent137 (53.8)6 (46.2)0.003
Present477 (14.9)40 (85.1)
Perineural invasionAbsent2511 (44.0)14 (56.0)0.009
Present10921 (19.3)88 (80.7)
pT1T1105 (50.0)5 (50.0)0.170
T2438 (18.6)35 (81.4)
T34612 (26.1)34 (73.9)
T4326 (18.8)26 (81.2)
pN1Absent8421 (25.0)63 (75.0)0.725
Present4510 (22.2)35 (77.8)
pTNM1I327 (21.9)25 (78.1)0.895
II308 (26.7)22 (73.3)
III339 (27.3)24 (72.7)
IV347 (20.6)27 (79.4)